Our results suggest that the downregulation of PIGR, HEPACAM2 and ADH1C and upregulation of teneurin-2 expression contribute to the pathology of the ocular surface in patients with SJS in the chronic stage. This evidence concerns the gene HEPACAM2 and Schwartz-Jampel syndrome.